Frejd Fredrik Y, Kim Kyu-Tae
Affibody AB, Solna, Sweden.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Exp Mol Med. 2017 Mar 24;49(3):e306. doi: 10.1038/emm.2017.35.
Affibody molecules can be used as tools for molecular recognition in diagnostic and therapeutic applications. There are several preclinical studies reported on diagnostic and therapeutic use of this molecular class of alternative scaffolds, and early clinical evidence is now beginning to accumulate that suggests the Affibody molecules to be efficacious and safe in man. The small size and ease of engineering make Affibody molecules suitable for use in multispecific constructs where AffiMabs is one such that offers the option to potentiate antibodies for use in complex disease.
亲和体分子可作为诊断和治疗应用中分子识别的工具。关于这类替代支架分子在诊断和治疗方面的应用,已有多项临床前研究报道,目前早期临床证据也开始积累,表明亲和体分子在人体中有效且安全。亲和体分子体积小且易于工程化改造,适用于多特异性构建体,其中AffiMabs就是这样一种构建体,它为增强抗体在复杂疾病中的应用提供了选择。